Virtual Dinner Program: Full Presentation | Cxbladder

Full presentation from our recent Virtual Dinner Program event.

Cxbladder is a non-invasive genomic urine test designed to detect or rule out bladder cancer in hematuria patients, and those being monitored for bladder recurrence following treatment.

- Accurate rule out, reducing the need for further invasive procedures
- Resolve atypical cytology and equivocal cystoscopy
- Improve overall detection accuracy

Cxbladder is covered by Medicare, and comes with the option of patient in-home sampling to simplify and streamline the bladder cancer testing process.